25 set - Roma
Altro
Università di Torino seeks a researcher to study transcription factors mediating resistance to therapies in acute myeloid leukemia, focusing on BCL-2 inhibitor venetoclax. The project uses molecular techniques and cellular assays to uncover resistance mechanisms.
The candidate must hold a Laurea Magistrale or equivalent and be within six years of the degree date; further details are available in the official call published by the university.
#J-18808-Ljbffr
26 set - Ubersetto
Fine Foods & Pharmaceuticals N.T.M.
26 set - Napoli
Nextar Consulting
26 set - Pavia
Technical Hunters
26 set - Milano
Icon Clinical